Cover: Potential Effects of Introducing Behind the Counter Drugs

Potential Effects of Introducing Behind the Counter Drugs

Published Sep 25, 2008

by Neeraj Sood, Eric Sun, Xiaohui Zhuo, Margaret E. Blume-Kohout

Download eBook for Free

FormatFile SizeNotes
PDF file 0.3 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

In an effort to increase access to select low-toxicity drugs by eliminating the costs associated with obtaining a physician's prescription, the Food and Drug Administration is considering a third classification, called behind-the-counter (BTC) drugs. These drugs would be available without a physician's prescription but, unlike over-the-counter (OTC) drugs, would not be freely available to patients. Rather, they would be available only in pharmacies and upon consultation with a pharmacist. Although the United States has limited experience with BTC drugs, other countries have introduced the BTC class, and their experiences can provide insight into the potential effects of this new class of drugs. The authors examine the potential effects of introducing BTC drugs by looking at experience with OTC drugs. The results of their analyses suggest that the introduction of BTC drugs in the United States could have varied effects in practice, and it is unclear whether such a policy would increase access to drugs, reduce medical costs, or increase health.

The research in this report was conducted by RAND Health and prepared for the Office of the Assistant Secretary for Planning and Evaluation,United States Department of Health and Human Services.

This report is part of the RAND working paper series. RAND working papers are intended to share researchers' latest findings and to solicit informal peer review. They have been approved for circulation by RAND but may not have been formally edited or peer reviewed.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.